Opsahl J A, Husebye D G, Helseth H K, Collins A J
Division of Nephrology, Hennepin County Medical Center, Minnesota, Minneapolis 55415.
Am J Kidney Dis. 1988 Oct;12(4):271-4. doi: 10.1016/s0272-6386(88)80219-1.
Coronary artery bypass grafting (CABG) can be performed with acceptable risk and results in symptomatic improvement in patients with end-stage renal disease (ESRD). However, the effect of CABG on long-term survival in these patients is unknown. We retrospectively identified 39 patients (group 1) with ESRD who underwent CABG for intractable angina between January 1975 and February 1987 while on maintenance dialysis. Thirty-nine dialysis patients (group 2) were also retrospectively selected for comparison and matched for age, sex, year of initiation, length of time on dialysis, and presence of diabetes mellitus and atherosclerotic heart disease at initiation of dialysis. Using life-table analysis, survival probability (with 95% confidence limits) was determined from the time of CABG for group 1 or after an equivalent period of time on dialysis for group 2. Two life-table analyses were performed; one with study end-points of death, withdrawal (renal transplantation, transfer to other dialysis facilities, and reoperation), and alive on dialysis; and a second with identical end points except that noncardiac deaths were treated as withdrawals. Coronary arteriography revealed severe three vessel disease, left ventricular dysfunction, and segmental wall motion abnormalities in most patients. A mean (+/- SD) of 2.56 +/- 0.75 vessels were bypassed with an operative mortality (30 days) of 2.6%. Mean follow-up after CABG in group 1 was 34.9 +/- 30.1 months, and in most patients functional classification improved. Mean follow-up for group 2 was 17.2 +/- 15.2 months. Two-year survival was 91.7% in group 1 and 51.4% in group 2 (P less than 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)
冠状动脉旁路移植术(CABG)可在可接受的风险下进行,且能使终末期肾病(ESRD)患者的症状得到改善。然而,CABG对这些患者长期生存的影响尚不清楚。我们回顾性确定了1975年1月至1987年2月期间因顽固性心绞痛接受CABG的39例ESRD患者(第1组),这些患者当时正在接受维持性透析。还回顾性选择了39例透析患者(第2组)进行比较,两组在年龄、性别、开始透析年份、透析时间长短以及透析开始时是否存在糖尿病和动脉粥样硬化性心脏病方面进行了匹配。使用生命表分析,从第1组CABG时间或第2组同等透析时间后确定生存概率(95%置信区间)。进行了两项生命表分析;一项分析的研究终点为死亡、退出(肾移植、转至其他透析机构和再次手术)以及仍在接受透析;另一项分析的终点相同,但将非心脏性死亡视为退出。冠状动脉造影显示大多数患者存在严重的三支血管病变、左心室功能障碍和节段性室壁运动异常。平均(±标准差)2.56±0.75支血管接受了旁路移植,手术死亡率(30天)为2.6%。第1组CABG后的平均随访时间为34.9±30.1个月,大多数患者的功能分级有所改善。第2组的平均随访时间为17.2±15.2个月。第1组的两年生存率为91.7%,第2组为51.4%(P<0.05)。(摘要截短于250字)